EUVIMEDEUVIMED entdecken
Crossref

Mitochondrial-derived vesicles: Rethinking a quality control pathway as a therapeutic opportunity

Fatima Elmusa, Mohammadreza Dastouri

Biomedicine Advances · 27.04.2026 · 3 (2) · 44-46

DOI: 10.34172/bma.68 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedicine Advances, online erschienen am 27.04.2026. Verfasst von Fatima Elmusa und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Elmusa, F., & Dastouri, M. (2026). Mitochondrial-derived vesicles: Rethinking a quality control pathway as a therapeutic opportunity. Biomedicine Advances, 3(2), 44-46. https://doi.org/10.34172/bma.68

Vancouver

Elmusa F, Dastouri M. Mitochondrial-derived vesicles: Rethinking a quality control pathway as a therapeutic opportunity. Biomedicine Advances. 2026;3(2):44-46. doi:10.34172/bma.68

BibTeX
@article{Elmusa2026,
  author = {Elmusa, Fatima and Dastouri, Mohammadreza},
  title = {Mitochondrial-derived vesicles: Rethinking a quality control pathway as a therapeutic opportunity},
  journal = {Biomedicine Advances},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {44--46},
  doi = {10.34172/bma.68}
}
Kostenlos starten →